MGM Resorts International diskutieren
MGM Resorts International
WKN: 880883 / Symbol: MGM / Name: MGM Resorts Intl / Aktie / Hotels & Unterhaltung / Large Cap /
31,58 €
-0,57 %
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $57.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Barclays PLC from $56.00 to $54.00. They now have an "overweight" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Wells Fargo & Company from $53.00 to $47.00. They now have an "overweight" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Truist Financial Co. from $58.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Mizuho from $57.00 to $56.00. They now have an "outperform" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Barclays PLC from $54.00 to $50.00. They now have an "overweight" rating on the stock.
Ratings data for MGM provided by MarketBeat
Der Beitrag wird untersucht
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Barclays PLC from $50.00 to $46.00. They now have an "overweight" rating on the stock.
Ratings data for MGM provided by MarketBeat
Der Beitrag wird untersucht
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Jefferies Financial Group Inc. from $52.00 to $50.00. They now have a "buy" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target raised by analysts at Capital One Financial Co. from $52.00 to $56.00. They now have an "overweight" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target raised by analysts at Stifel Nicolaus from $47.00 to $50.00. They now have a "buy" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target raised by analysts at Mizuho from $56.00 to $60.00. They now have an "outperform" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target raised by analysts at Wells Fargo & Company from $44.00 to $46.00. They now have an "overweight" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target raised by analysts at Citigroup Inc. from $48.00 to $50.00. They now have a "buy" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its "outperform" rating re-affirmed by analysts at Macquarie. They now have a $50.00 price target on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $50.00 price target on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Barclays PLC from $47.00 to $41.00. They now have an "overweight" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target lowered by analysts at Truist Financial Co. from $50.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for MGM provided by MarketBeat
MGM Resorts International (NYSE: MGM) had its price target raised by analysts at Susquehanna from $45.00 to $50.00. They now have a "positive" rating on the stock.
Ratings data for MGM provided by MarketBeat


Neueste Beiträge
SVB_Leerink_LLC in Ultragenyx Pharmaceutical Inc. diskutieren